Yüklüyor......
Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer
Identifying the presence or absence of a BRAF(V600E) mutation is paramount for the management of patients with metastatic colorectal cancer (mCRC) as there is distinct predictive and prognostic implications, as well as unique therapeutic approaches for this molecular subtype. Traditional cytotoxic d...
Kaydedildi:
| Yayımlandı: | Target Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7583680/ https://ncbi.nlm.nih.gov/pubmed/32889679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-020-00747-5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|